Open AccessP449: NOVEL, FIRST‐IN‐CLASS, SOMATIC IDH2 DELETION‐INSERTION VARIANT C.516_518DELINSTGC CONFERS BORDERLINE PHENOTYPE AND DOES NOT SHOW SUSCEPTIBILITY TO ENASIDENIB IN‐VITRO
Author(s) -
Ruhnke L.,
Poitz D. M.,
Herold S.,
Dressler S.,
Dill C.,
Peitzsch M.,
Oelschlägel U.,
Frimmel J.,
Kunadt D.,
Kretschmann T.,
Altmann H.,
Stölzel F.,
Röllig C.,
Chavakis T.,
Baretton G.,
SchäferEckart K.,
Bornhäuser M.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000844684.27646.05
Subject(s) - idh2 , cebpa , npm1 , biology , sanger sequencing , cancer research , genetics , microbiology and biotechnology , mutation , karyotype , chromosome , idh1 , gene